Identifying Inhibitors for Tuberculosis Treatment
Author Information
Author(s): Garima Khare, Ritika Tyagi, Anil K. Tyagi, Leonardo A. Sechi
Primary Institution: Department of Biochemistry, University of Delhi, New Delhi, India
Hypothesis
Can thiamin phosphate synthase (MtTPS) be targeted to develop new inhibitors against Mycobacterium tuberculosis?
Conclusion
The study identified a potent inhibitor of MtTPS with an MIC99 value of 6 µg/ml, suggesting its potential as a lead compound for anti-tuberculosis drug development.
Supporting Evidence
- Seven compounds were found to inhibit MtTPS activity with IC50 values ranging from 20 to 100 µg/ml.
- Compound 9 was identified as a very potent inhibitor with an MIC99 value of 6 µg/ml against M.tuberculosis.
- The study emphasizes the importance of MtTPS as a target for developing new anti-tuberculosis drugs.
Takeaway
Researchers found a new way to fight tuberculosis by discovering a compound that stops a key enzyme in the bacteria from working.
Methodology
The study used virtual screening of compounds against a homology model of MtTPS and evaluated their inhibitory effects in vitro.
Limitations
The study primarily focused on a limited set of compounds and their effects on MtTPS without extensive in vivo testing.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website